By David Tuller, DrPH I recently posted a blog about the protocol for a Canadian Long COVID exercise trial in which the investigators proposed lying to the participants about the nature of both the study and the intervention being assessed. While acknowledging that a significant number of people with Long COVID report experiencing post-exertional malaise …
By David Tuller, DrPH Researchers are planning yet another trial of a rehabilitative exercise program for Long COVID—but, in this one, they propose to lie to all the participants about the nature of the study and the intervention being investigated. BMJ Open has recently published a paper called “Pursuing Reduction in Fatigue After COVID-19 via …
By David Tuller, DrPH McMaster University, in Hamilton, Ontario, seems to be Canada’s Ground Zero for psychosomatic theorizing. In March, 2021, a psychiatrist-in-training, Jeremy Devine, published an opinion in The Wall Street Journal titled “The Dubious Origins of Long Covid.” (I wrote about it here.) Devine cited the PACE trial favorably, as if its findings …
By David Tuller, DrPH A group called Canadian Guidelines for Post COVID-19 Condition (CAN-PCC) has released a new set of draft recommendations related to preventing, diagnosing and treating what is commonly called Long Covid. The current list of nine draft recommendations includes exercise and cognitive behavior therapy, which has understandably raised concerns among advocates for …
The influenza A (H1N1) 2009 vaccine produced by GlaxoSmithKline has been approved by Canada Health. Here is some information on the vaccine to supplement what I’ve provided about the US counterparts. The Canadian vaccine, called Arepanrix H1N1, is supplied in two parts. One contains inactivated H1N1 influenza virus, and the second consists of AS03 adjuvant …
